For severe pain, prescription narcotics are available.
Narcotics, like all pain medications, can be used for both acute and chronic pain.
Narcotics are also divided into categories, called Schedules, by the government. Hydrocodone compounds, such as Vicodin, are Schedule III; many other narcotics are in Schedule II. For the patient, a major difference is that a physician can call or fax in a Schedule III prescription to the pharmacy, whereas a Schedule II medication requires a tamper proof prescription which the patient must deliver directly to the pharmacy.
Narcotics can be classified as either immediate release, with an effect lasting several hours, or sustained release, with effects lasting anywhere from eight hours to three days. Physicians use the sustained release forms primarily for chronic pain, where there is a continual need for pain relief. The intent is that by providing constant relief, the person suffering from chronic pain can focus on living their life (maintaining function) rather than constantly worrying about taking the next pill. In this way, physicians hope to minimize the occurrence of addiction.
Immediate release medications are used in the chronic pain setting to treat breakthrough pain, or short-lived (up to about an hour) pain which occurs because of increased activity or sometimes for no reason at all. Breakthrough episodes, if they do occur, can occur up to three to four times per day. There are many commonly prescribed immediate release medications, including preparations of morphine, oxycodone, hydromorphone, oxycodone, meperidine, oxymorphone and fentanyl. Most of these medications are pills. Fentanyl comes in two preparations, Actiq and Fentora, which allow it to be absorbed into the blood stream through the lining of the mouth. Actiq and Fentora have the advantage of vary fast onset and have been approved by the FDA for cancer breakthrough pain.
The following are five commonly prescribed sustained release narcotic medications:
Meperidine (Demerol) is not a very effective oral pain medication and should not be used as such. With all opioids, the major side effects are sedation, nausea, and constipation. Anyone taking narcotics should treat possible constipation, by maintaining a high fluid intake, a high fiber diet, and using stool softeners.
The purpose of prescribing opioids for chronic pain is to allow someone who is in pain to function more normally. If someone is too sedated from the opioids to function, then the medications being prescribed should be re-evaluated or possibly a pump should be used to deliver the medications into the intrathecal space (into the cerebrospinal fluid that surrounds the brain and spinal cord).
Most people using chronic opioid therapy do drive. It is up to each individual who is taking narcotics to determine whether they are alert enough to drive. If someone taking opioids is involved in a traffic accident, they can be charged with driving under the influence.
An interesting new sustained release medication is tramadol (Ultram ER). It is not placed in a Schedule by the FDA, because the FDA does not believe that there is significant abuse potential with this drug. It also has the advantage of being used once per day. While it is a less strong analgesic than the "scheduled" narcotics, it is very useful in some chronic pain patients who do not require stronger analgesics and also in patients who have a history of substance abuse whose physicians wish to avoid scheduled medications.
| Printer-Friendly Format | | | Email to a Friend |
Find tips and advances in treatment.
Cymbalta is approved for the treatment of fibromyalgia.
Important Safety Information
Cymbalta® (duloxetine HCl) is approved for the treatment of depression and generalized anxiety disorder, and for the management of diabetic peripheral neuropathic pain and fibromyalgia.
Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, unusual changes in behavior, thoughts of suicide, anxiety, agitation, panic attacks, difficulty sleeping, irritability, hostility, aggressiveness, impulsivity, restlessness, or extreme hyperactivity. Call your healthcare provider right away if you have thoughts of suicide or if any of these symptoms are severe or occur suddenly. Be especially observant within the first few months of antidepressant treatment or whenever there is a change in dose.
You should not take Cymbalta if:
Before starting Cymbalta, tell your healthcare provider:
While taking Cymbalta, tell your healthcare provider:
If you have any questions, talk to your healthcare provider before taking Cymbalta.
The most common side effect of Cymbalta was nausea. For most people who had it, the nausea was mild to moderate. Other common side effects included dry mouth, sleepiness, constipation, decreased appetite, and, increased sweating. This is not a complete list of side effects.
This article focuses on the use of therapeutic injections to treat acute and chronic pain syndromes.
|